KORU Medical Systems, Inc. - 8-K Filing Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2025 Annual Meeting of Shareholders held on May 14, 2025. The filing covers the voting outcomes for director elections, executive compensation approval, and the ratification of independent auditors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 36,949,703 shares were voted at the meeting. The outcomes for the three proposals were as follows:
- Proposal 1 (Election of Directors): All seven nominees were elected. Broker non-votes totaled 12,997,325 shares for each nominee. The highest number of "For" votes was received by Edward Wholihan (23,905,034), and the lowest by Robert A. Cascella (23,574,888).
- Proposal 2 (Executive Compensation): Shareholders approved the compensation of executive officers on an advisory basis. Votes cast were 23,167,952 For, 702,827 Against, and 81,599 Abstain.
- Proposal 3 (Ratification of Auditors): Shareholders ratified the appointment of Cherry Bekaert LLP as the independent registered public accountants for the 2025 fiscal year. Votes cast were 36,910,101 For, 9,621 Against, and 29,981 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to calculate the percentage of shares represented at the meeting.
- Confirm the specific terms of the executive compensation package approved under Proposal 2.
- Review the full proxy statement for details on the director nominees and their qualifications.
- Check subsequent filings for the company's financial performance for the fiscal year ending 2025.